1
689 obstetric physiology and supported by midwives or technicians trained and equipped to measure uterine forces, control infusions on a rational basis and diagnose impending foetal distress. Such a service is needed round the clock. So often funds are short because those in control of policy are unaware of the clinical value of recent obstetric research. There is a real need for a centre at which the benefit of physiological measurements can be demonstrated to the obstetrician and also to the midwife. Mr. Williams performs a service in again reminding readers to make the gravitational correction if the intra- uterine pressure is not measured at the highest point of the uterus when the patient is supine. Unfortunately, he has misquoted our intentions when he writes that the hand is to be preferred to objective measurements. We find no evidence that man is endowed with an absolute sense of pressures, or sense of urgency for prevention of perinatal mortality or morbidity. W. C. W. NIXON C. N. SMYTH. Obstetric Hospital, University College Hospital, London, W.C.1. THE PREMATURE PERSUADERS SIR, Your leading article of Jan. 27 has been criticised in an interesting article in The Chemist and Druggist Feb. 3. This editorial questions your view that controlled therapeutic trials should be done before a new drug is marketed, and states quite correctly that all reputable pharmaceutical firms carry out extensive animal toxicity tests and clinical trials before marketing new drugs. Their criticism is, I think, due to a failure to appreciate that uncontrolled clinical trials cannot, except in a few rare instances, show whether a new drug is or is not more effective than existing remedies. In the absence of clear evidence on this point, it is not justifiable to use any new drug other than in exceptional circumstances for there is always a possibility of harm being done to patients of the sort which cannot be shown by animal toxicity tests or by ordinary short-term clinical trials. Even if a properly controlled therapeutic trial has shown that the new drug is of value, and despite satisfactory animal toxicity tests, there is still the possibility of unpredictable and sometimes very serious toxic actions, and this is why I believe that there should still be one more safeguard before any drug is widely marketed. I think its initial use on a larger scale than is possible during clinical trials should be kept under very close supervision. In the first paragraph of its editorial, The Chemist and Druggist states that The Lancet has cast a slur on the manufacturers of pharmaceutical specialities by its criticism, and in the last paragraph it is so inconsiderate of the Cohen Committee as to suggest that a wider knowledge of its classification of the therapeutic value of new drugs would be of no use to doctors. These com- ments " tinged with emotion " are a manifestation of a conflict between the pharmaceutical industry, anxious to market drugs commercially, and the medical profession, anxious to use drugs, anxious to have new drugs developed, but increasingly anxious to use only drugs of real value and to avoid the tragedy of iatrogenic disease caused by drugs. The main concern of both the doctor and the pharmaceutical industry should be with the well-being of our patients; if this demands a more cautious use of new drugs by doctors and has repercussions in the commercial practices of the pharmaceutical industry, these changes must be accepted not castigated. Many of the problems will require the greatest cooperation and goodwill between doctors and the industry. O. L. WADE. Department of Therapeutics and Pharmacology, Queen’s University of Belfast. THE RISK OF AN OPERATION SIR,-It was interesting to see from Mr. Skyrme Rees’s letter of March 17 that 86% of the so-called " irreducible minimum mortality of surgery " is due to pulmonary embolism. If this is indeed so, then I feel that there is still great hope of reducing the risk of an operation still further for, from my own experience, I am utterly convinced that postoperative pulmonary embolism could soon be rele- gated to the limbo of forgotten things if only we could educate hospital staffs in the principles of venous return. All my patients and those of many of my surgical friends have the foot of their bed raised 9 in. postoperatively and, even more important, they are shown simple flexion and extension movements of the ankle which they carry out until they leave hospital. If they are shown these by the nursing staff, who bellow them into their ear as they recover from the anaesthetic, then they have no problem in remembering to carry them out. (I suppose one could fairly say that they are hypnotised.) In this way, venous blood is never allowed to lie fallow and stagnate, the normal rapid venous return is maintained and the risk of thrombosis eliminated. We should also wipe out this pernicious habit of pushing patients out of bed on the first or second postoperative day so that they can stagnate in an armchair. I personally have no objection to early postoperative rising provided that the patients are either able to walk (wearing well-fitting lace-up shoes instead of sloppy shambling slippers) or are encouraged to " walk " while sitting in a chair by moving their ankles up and down every now and again as if beating time to music. Provided we remember that venous return from the lower limbs is governed almost entirely by the calf-muscle pump which, in turn, is operated by flexion and extension movements of the ankle, we have it within our power to abolish the bogy of pulmonary embolism, a subject which has provided material for papers and leading articles for far too many years. STANLEY RIVLIN. London, W.1. SIR,-I was honoured to read in your columns of March 24 a letter in answer to mine from Mr. McNeill Love, whom I have greatly admired as a stimulating and perceptive teacher of surgery, to whom I owe a great deal in the past 32 years. In considering whether raising the heels of a patient undergoing operation is an effective prophylactic measure, and indeed, if there is any prophylaxis to fatal pulmonary embolus, I respectfully invite him to consider the follow- ing figures. The 6 patients mentioned in my letter of March 17 who died from pulmonary embolism after appendicectomy were all under 60: 1 was 23, 2 were in their 30s, and the others in their 50s. There was no indication from the records whether the heels were raised. In the five years 1944-48, of all the postmortem examinations performed at Dudley Road Hospital, Birmingham, 52 patients were found to be dead of pulmonary embolism, yet only 17 of these had been subject to operation. Of the remainder 34 died in medical or surgical wards without ever lying on an operating-table, and 1 had been brought to the hospital already dead. Of the total of 52 patients who died of pulmonary embolism, 18 were under 60 years of age-that is, 35%. Of the 17 who died after operation, 6 (35%) were under 60. Of the 35 who died without operation 14 (40%) were under 60. Of these 35, 20 died in medical wards, and of these 20, 8 (40%,) were under

THE PREMATURE PERSUADERS

  • Upload
    ol

  • View
    214

  • Download
    0

Embed Size (px)

Citation preview

Page 1: THE PREMATURE PERSUADERS

689

obstetric physiology and supported by midwives or

technicians trained and equipped to measure uterine

forces, control infusions on a rational basis and diagnoseimpending foetal distress. Such a service is needed roundthe clock. So often funds are short because those incontrol of policy are unaware of the clinical value ofrecent obstetric research. There is a real need for a

centre at which the benefit of physiological measurementscan be demonstrated to the obstetrician and also to themidwife.Mr. Williams performs a service in again reminding

readers to make the gravitational correction if the intra-uterine pressure is not measured at the highest point ofthe uterus when the patient is supine. Unfortunately, hehas misquoted our intentions when he writes that thehand is to be preferred to objective measurements. Wefind no evidence that man is endowed with an absolutesense of pressures, or sense of urgency for prevention ofperinatal mortality or morbidity.

W. C. W. NIXONC. N. SMYTH.

Obstetric Hospital,University College Hospital,

London, W.C.1.

THE PREMATURE PERSUADERS

SIR, Your leading article of Jan. 27 has been criticisedin an interesting article in The Chemist and DruggistFeb. 3. This editorial questions your view that controlledtherapeutic trials should be done before a new drug ismarketed, and states quite correctly that all reputablepharmaceutical firms carry out extensive animal toxicitytests and clinical trials before marketing new drugs. Theircriticism is, I think, due to a failure to appreciate thatuncontrolled clinical trials cannot, except in a few rareinstances, show whether a new drug is or is not moreeffective than existing remedies. In the absence of clearevidence on this point, it is not justifiable to use any newdrug other than in exceptional circumstances for there isalways a possibility of harm being done to patients of thesort which cannot be shown by animal toxicity tests or byordinary short-term clinical trials. Even if a properlycontrolled therapeutic trial has shown that the new drugis of value, and despite satisfactory animal toxicity tests,there is still the possibility of unpredictable and sometimesvery serious toxic actions, and this is why I believe thatthere should still be one more safeguard before any drugis widely marketed. I think its initial use on a larger scalethan is possible during clinical trials should be kept undervery close supervision.

In the first paragraph of its editorial, The Chemist andDruggist states that The Lancet has cast a slur on themanufacturers of pharmaceutical specialities by its

criticism, and in the last paragraph it is so inconsiderateof the Cohen Committee as to suggest that a wider

knowledge of its classification of the therapeutic value ofnew drugs would be of no use to doctors. These com-ments

" tinged with emotion " are a manifestation of aconflict between the pharmaceutical industry, anxious tomarket drugs commercially, and the medical profession,anxious to use drugs, anxious to have new drugs developed,but increasingly anxious to use only drugs of real valueand to avoid the tragedy of iatrogenic disease caused bydrugs. The main concern of both the doctor and thepharmaceutical industry should be with the well-beingof our patients; if this demands a more cautious use ofnew drugs by doctors and has repercussions in thecommercial practices of the pharmaceutical industry,these changes must be accepted not castigated. Many of

the problems will require the greatest cooperation andgoodwill between doctors and the industry.

O. L. WADE.Department of Therapeutics and Pharmacology,Queen’s University of Belfast.

THE RISK OF AN OPERATION

SIR,-It was interesting to see from Mr. Skyrme Rees’sletter of March 17 that 86% of the so-called

" irreducibleminimum mortality of surgery " is due to pulmonaryembolism. If this is indeed so, then I feel that there is still

great hope of reducing the risk of an operation still furtherfor, from my own experience, I am utterly convinced thatpostoperative pulmonary embolism could soon be rele-gated to the limbo of forgotten things if only we couldeducate hospital staffs in the principles of venous return.

All my patients and those of many of my surgical friendshave the foot of their bed raised 9 in. postoperatively and, evenmore important, they are shown simple flexion and extensionmovements of the ankle which they carry out until they leavehospital. If they are shown these by the nursing staff, whobellow them into their ear as they recover from the anaesthetic,then they have no problem in remembering to carry them out.(I suppose one could fairly say that they are hypnotised.) Inthis way, venous blood is never allowed to lie fallow and

stagnate, the normal rapid venous return is maintained andthe risk of thrombosis eliminated.We should also wipe out this pernicious habit of pushing

patients out of bed on the first or second postoperative day sothat they can stagnate in an armchair. I personally have noobjection to early postoperative rising provided that the

patients are either able to walk (wearing well-fitting lace-upshoes instead of sloppy shambling slippers) or are encouragedto

" walk " while sitting in a chair by moving their ankles upand down every now and again as if beating time to music.

Provided we remember that venous return from thelower limbs is governed almost entirely by the calf-musclepump which, in turn, is operated by flexion and extensionmovements of the ankle, we have it within our power toabolish the bogy of pulmonary embolism, a subject whichhas provided material for papers and leading articles forfar too many years.

STANLEY RIVLIN.London, W.1.

SIR,-I was honoured to read in your columns ofMarch 24 a letter in answer to mine from Mr. McNeill

Love, whom I have greatly admired as a stimulating andperceptive teacher of surgery, to whom I owe a great dealin the past 32 years.

In considering whether raising the heels of a patientundergoing operation is an effective prophylactic measure,and indeed, if there is any prophylaxis to fatal pulmonaryembolus, I respectfully invite him to consider the follow-ing figures.The 6 patients mentioned in my letter of March 17 who died

from pulmonary embolism after appendicectomy were allunder 60: 1 was 23, 2 were in their 30s, and the others in their50s. There was no indication from the records whether theheels were raised.

In the five years 1944-48, of all the postmortem examinationsperformed at Dudley Road Hospital, Birmingham, 52 patientswere found to be dead of pulmonary embolism, yet only 17of these had been subject to operation. Of the remainder 34died in medical or surgical wards without ever lying on anoperating-table, and 1 had been brought to the hospital alreadydead.Of the total of 52 patients who died of pulmonary embolism,

18 were under 60 years of age-that is, 35%. Of the 17 whodied after operation, 6 (35%) were under 60. Of the 35 whodied without operation 14 (40%) were under 60. Of these 35,20 died in medical wards, and of these 20, 8 (40%,) were under